EUVIMEDEUVIMED entdecken
Multizentrische StudieVergleichsstudieOpen Access · CC BY 4.0

A Multicentre, 4‐Year Mirror‐Image Study Comparing the Effectiveness of Long‐Acting Injectable Antipsychotics in the Treatment of Bipolar Disorder: Results From the LAICO Study

Juan Antonio García-Carmona iD, Joshua Barnett, María Pilar Campos-Navarro, Katie Mason, Jorge Simal-Aguado, Sofia Pappa

Bipolar Disorders · 2026

DOI: 10.1111/bdi.70080 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Bipolar Disorders, 2026. Verfasst von Juan Antonio García-Carmona und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Santa Lucia University Hospital, Murcia, Spain. Hauptthemen laut MEDLINE: Antipsychotic Agents, Bipolar Disorder, Paliperidone Palmitate, Risperidone. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This was a 4‐year mirror‐image study of adult patients diagnosed with bipolar disorder (BD) assessing the effects on treatment continuation and hospitalisation between aripiprazole 1‐month (A1M), risperidone‐LAI (R‐LAI) and the monthly and 3‐monthly formulations of paliperidone palmitate (PP1M, PP3M). We aimed to evaluate and compare the use of A1M, R‐LAI, and the monthly and 3‐monthly formulations of paliperidone palmitate (PP1M, PP3M) by using the change of number and length of hospitalisations 2 years before compared to 2 years after initiation of LAIs for continuers and discontinuers. Secondary outcomes were: (1) discontinuation rates at 2 years and reasons per LAI, (2) time to discontinuation per LAI, and (3) time to first hospitalisation per LAI.

Results

A total of 122 BD were included; 74 continued LAI treatment at two years. Reasons for discontinuation were poor compliance (50%), ineffectiveness (43.2%), and tolerability issues (13.6%). Both time to individual LAI discontinuation and time to first hospital admission were significantly lower in the R‐LAI group. There was a significant overall reduction in the number and length of hospitalisations two years before and after LAI initiation, although multivariate logistic regression analysis showed that A1M, PP1M and R‐LAI were associated with an increased risk (OR = 1.89, 95% CI = 1.54–3.68, p = 0.015; OR = 1.63, 95% CI = 1.29–2.77, p = 0.022; OR = 3.08, 95% CI = 1.48–6.05, p = 0.008, respectively) of bed usage compared to PP3M. Last, study completers showed a considerable drop of 79% in number of hospital admissions and 83% in bed days ( p = 0.001) as opposed to non‐completers.

Conclusions

Study findings suggest that long‐acting antipsychotics such as A1M, PP1M, and particularly PP3M are associated with high retention and lower hospitalisation rates after 2 years of treatment in patients with BD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antipsychotic AgentsBipolar DisorderPaliperidone PalmitateRisperidoneAripiprazoleHumansFemaleMaleDelayed-Action PreparationsAdultMiddle AgedTreatment OutcomeHospitalization

Stichwörter der Autor:innen

aripiprazole 1‐monthbipolar disorderlong‐acting injectable antipsychoticspaliperidone‐palmitate 1‐monthlypaliperidone‐palmitate 3‐monthly

Substanzen

Antipsychotic AgentsPaliperidone PalmitateRisperidoneAripiprazoleDelayed-Action Preparations

Autor:innen und Institutionen

  • Department of Neurology, Santa Lucia University Hospital, Murcia, Spain.
  • Group of Clinical and Experimental Pharmacology, Institute for Biomedical Research of Murcia (IMIB), Murcia, Spain.
  • Faculty of Health Sciences, University of Murcia, Murcia, Spain.
  • West London National Health System (NHS) Trust, London, UK.
  • Department of Psychiatry, Santa Lucía University Hospital, Murcia, Spain.
  • Department of Brain Sciences, Faculty of Medicine, Imperial College of London, London, UK.

ORCID-Profile: Juan Antonio García-Carmona

Zitieren

APA

García-Carmona, J. A., Barnett, J., Campos-Navarro, M. P., Mason, K., Simal-Aguado, J., & Pappa, S. (2026). A Multicentre, 4‐Year Mirror‐Image Study Comparing the Effectiveness of Long‐Acting Injectable Antipsychotics in the Treatment of Bipolar Disorder: Results From the LAICO Study. Bipolar Disorders. https://doi.org/10.1111/bdi.70080

Vancouver

García-Carmona JA, Barnett J, Campos-Navarro MP, Mason K, Simal-Aguado J, Pappa S. A Multicentre, 4‐Year Mirror‐Image Study Comparing the Effectiveness of Long‐Acting Injectable Antipsychotics in the Treatment of Bipolar Disorder: Results From the LAICO Study. Bipolar Disorders. 2026. doi:10.1111/bdi.70080

BibTeX
@article{GarcaCarmona2026,
  author = {García-Carmona, Juan Antonio and Barnett, Joshua and Campos-Navarro, María Pilar and Mason, Katie and Simal-Aguado, Jorge and Pappa, Sofia},
  title = {A Multicentre, 4‐Year Mirror‐Image Study Comparing the Effectiveness of Long‐Acting Injectable Antipsychotics in the Treatment of Bipolar Disorder: Results From the LAICO Study},
  journal = {Bipolar Disorders},
  year = {2026},
  doi = {10.1111/bdi.70080}
}
Kostenlos starten →